Indication
Diabetic gastroparesis
Diabetic gastroparesis is a chronic neuromuscular complication of diabetes mellitus characterized by objectively delayed gastric emptying in the absence of mechanical gastric outlet obstruction. Read more about Diabetic gastroparesis
44 drugs 39 manufacturers
Drugs that treat it
Common Diabetic gastroparesis therapies.
METOCLOPRAMIDE HCL
METOCLOPRAMIDE HCL ODT (metoclopramide HCl)
METOZOLV ODT (metoclopramide HCl)
METOCLOPRAMIDE HCL ODT (metoclopramide HCl)
METOCLOPRAMIDE HCL
METOCLOPRAMIDE HCL
METOCLOPRAMIDE HCL
METOCLOPRAMIDE HCL ODT (metoclopramide HCl)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonDiabetic gastroparesis is a chronic neuromuscular complication of diabetes mellitus characterized by objectively delayed gastric emptying in the absence of mechanical gastric outlet obstruction.
Primarily affecting the gastrointestinal system in individuals with type 1 or type 2 diabetes, the disorder stems from autonomic neuropathy, enteric nerve damage, and loss of interstitial cells of Cajal, often exacerbated by chronic hyperglycemia.
Patients typically present with upper gastrointestinal symptoms including persistent nausea, vomiting, early satiety, postprandial fullness, abdominal bloating, and epigastric pain.
The resulting erratic transit of nutrients frequently causes unpredictable glucose absorption, leading to severe glycemic instability and nutritional compromise.
- nih.gov
Diabetic gastroparesis is a chronic neuromuscular complication of diabetes mellitus characterized by objectively delayed gastric emptying in the absence of mechanical gastric outlet obstruction Patients typically present with upper gastrointestinal symptoms including persistent nausea, vomiting, early satiety, postprandial fullness, abdominal bloating, and epigastric pain
- nih.gov
Diabetic gastroparesis is a chronic neuromuscular complication of diabetes mellitus characterized by objectively delayed gastric emptying in the absence of mechanical gastric outlet obstruction Primarily affecting the gastrointestinal system in individuals with type 1 or type 2 diabetes, the disorder stems from autonomic neuropathy, enteric nerve damage, and loss of interstitial cells of Cajal, often exacerbated by chronic hyperglycemia
- nih.gov
Primarily affecting the gastrointestinal system in individuals with type 1 or type 2 diabetes, the disorder stems from autonomic neuropathy, enteric nerve damage, and loss of interstitial cells of Cajal, often exacerbated by chronic hyperglycemia
- nih.gov
Patients typically present with upper gastrointestinal symptoms including persistent nausea, vomiting, early satiety, postprandial fullness, abdominal bloating, and epigastric pain
Personalize your experience
Follow Diabetic gastroparesis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.